17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) (Created page with "__NOTOC__ {{17-beta-hydroxysteroid dehydrogenase deficiency}} {{CMG}}; {{AE}} {{Abdulkerim}} ==Overview== If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, gender assignment should be discussed, depending on the expected result of virilization genioplasty. ==Medical therapy== *If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, gender assignment should be discused. Patients with this d...") |
Jose Loyola (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Abdulkerim}} | {{CMG}}; {{AE}} {{Abdulkerim}} | ||
==Overview== | ==Overview== | ||
Surgical therapy is guided by the risk of germ cell tumor development and to allow for proper gender assignment. | |||
== | ==Surgical therapy== | ||
* | *Patients with 17-beta hydroxysteroid dehydrogenase deficiency have moderate risk of germ cell tumor.<ref name="pmid2082839">{{cite journal| author=Melnik B, Hollmann J, Hofmann U, Yuh MS, Plewig G| title=Lipid composition of outer stratum corneum and nails in atopic and control subjects. | journal=Arch Dermatol Res | year= 1990 | volume= 282 | issue= 8 | pages= 549-51 | pmid=2082839 | doi=10.1007/BF00371952 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2082839 }} </ref> | ||
*Patients with | *These patients must be monitored closely, as the development of germ cell tumor requires the removal of the gonads. | ||
*Surgery can also be used to treat anatomic changes due to the hormonal disorder. Patients with this disease may present with ambiguous or female genitalia, despite most of them developing male gender identity. | |||
*Some studies have suggested that early surgical treatment may improve outcomes. Feminising genitoplasty usually requires less surgery interventions than masculinizing genitoplasty. Outcomes vary greatly in both cases. Many patients may present with risk of neoplasia associated with the neovagina, while regarding the masculinizing genitoplasty's results are heavily associated with the amount of erectile tissue and degree of hypospadias.<ref name="pmid2082839">{{cite journal| author=Melnik B, Hollmann J, Hofmann U, Yuh MS, Plewig G| title=Lipid composition of outer stratum corneum and nails in atopic and control subjects. | journal=Arch Dermatol Res | year= 1990 | volume= 282 | issue= 8 | pages= 549-51 | pmid=2082839 | doi=10.1007/BF00371952 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2082839 }} </ref> | |||
==References== | ==References== | ||
Revision as of 10:14, 13 October 2022
|
17-beta-hydroxysteroid dehydrogenase deficiency Microchapters |
|
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy On the Web |
|
American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy |
|
FDA on 17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy |
|
CDC on 17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy |
|
17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy in the news |
|
Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy |
|
Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdulkerim Yassin, M.B.B.S[2]
Overview
Surgical therapy is guided by the risk of germ cell tumor development and to allow for proper gender assignment.
Surgical therapy
- Patients with 17-beta hydroxysteroid dehydrogenase deficiency have moderate risk of germ cell tumor.[1]
- These patients must be monitored closely, as the development of germ cell tumor requires the removal of the gonads.
- Surgery can also be used to treat anatomic changes due to the hormonal disorder. Patients with this disease may present with ambiguous or female genitalia, despite most of them developing male gender identity.
- Some studies have suggested that early surgical treatment may improve outcomes. Feminising genitoplasty usually requires less surgery interventions than masculinizing genitoplasty. Outcomes vary greatly in both cases. Many patients may present with risk of neoplasia associated with the neovagina, while regarding the masculinizing genitoplasty's results are heavily associated with the amount of erectile tissue and degree of hypospadias.[1]
References
- ↑ 1.0 1.1 Melnik B, Hollmann J, Hofmann U, Yuh MS, Plewig G (1990). "Lipid composition of outer stratum corneum and nails in atopic and control subjects". Arch Dermatol Res. 282 (8): 549–51. doi:10.1007/BF00371952. PMID 2082839.